SY
Synact Pharma
Latest price
18.18 SEK
17/09/2026
SYNACT
3 mo
6 mo
1 yr+70.52%1 price targets
Max 2 price targets
HealthcareBiotechnology
Overview
Analysts
About The Company
SynAct Pharma is a clinical stage biotechnology company focused on resolving inflammation with melanocortin biology. Selective activation of the melanocortin system can help the immune system resolve excessive or chronic inflammation.
Synact Pharma
Consensus
Consensus
23.00 SEK
Upside
+26.51%
Based on older targets - no fresh targets in the last 90 days.
Latest price18.18 SEK
